---
title: "Ernexa Therapeutics Inc. SEC filings"
url: https://altstreet.investments/edgar/748592
kind: edgar-entity
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Ernexa Therapeutics Inc.: SEC filings and what they report

| Field | Value |
| --- | --- |
| Entity | Ernexa Therapeutics Inc. |
| CIK | 748592 |
| Filing family | Form D |
| Total offering amount (as filed) | $7,249,999 |
| Total sold (as reported) | $7,249,999 |
| Investors (as reported) | 15 |

## Filings (8 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| April 11, 2025 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000164117225003828/ |
| November 14, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000149315224045322/ |
| November 14, 2024 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000149315224045321/ |
| December 20, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000114036123058486/ |
| July 26, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000156761923006677/ |
| July 26, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000156761923006676/ |
| December 16, 2022 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000156761922021733/ |
| March 23, 2022 | D | Form D | https://www.sec.gov/Archives/edgar/data/748592/000156761922007387/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/748592
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000748592&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/748592
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
